BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38216945)

  • 21. Clinical efficacy of myometrial and endometrial microwave ablation in the treatment of patients with adenomyosis who had anemia.
    Li Z; Li X; Lin M; Qiu S; Wang L; Lai L; Luo X; Mo Z; Dong G; Lyu G; Li S
    Int J Hyperthermia; 2022; 39(1):1335-1343. PubMed ID: 36257919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of Transabdominal Ultrasound-guided Percutaneous Microwave Ablation in the Treatment of Symptomatic Adenomyosis: A Retrospective Cohort Study.
    Li S; Li Z; Lin M; Li X; Gao L; Qiu J; He J; Zhang J; Lyu G
    J Minim Invasive Gynecol; 2023 Feb; 30(2):137-146. PubMed ID: 36384213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful induction of ovulation and conception with combined gonadotropin-releasing hormone agonist plus highly purified follicle-stimulating hormone in patients with polycystic ovarian disease.
    Lanzone A; Fulghesu AM; Spina MA; Apa R; Menini E; Caruso A; Mancuso S
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1253-8. PubMed ID: 3119655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon).
    de Jong D; Macklon NS; Eijkemans MJ; Mannaerts BM; Coelingh Bennink HJ; Fauser BC;
    Fertil Steril; 2001 Apr; 75(4):688-93. PubMed ID: 11287020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relapse after conservative surgery combined with triptorelin acetate versus conservative surgery only in women with focal adenomyosis: study protocol for a multicenter, prospective, randomized controlled trial.
    Wang W; Ma X; Zhang W; Li Z; Wang Y; Yu Z; Zhang C; Hong L; Luo R; Xing H; Wang W; Yue Q; Wei J; Zhang M; Wang S
    Trials; 2020 Apr; 21(1):364. PubMed ID: 32345377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of related factors influencing postoperative recurrence of adenomyosis treated with HIFU.
    Fan LX; Zhang Y; Yang LL; Ji XL; Wang Y; Huang YF; Shi L; Wen Y
    Arch Gynecol Obstet; 2024 May; 309(5):1765-1773. PubMed ID: 38347252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of pre-treatment with gonadotropin-releasing hormone analogue GnRH-α on high-intensity focussed ultrasound ablation for diffuse adenomyosis: a preliminary study.
    Xiao-Ying Z; Ying-Shu G; Jiu-Mei C; Jin-Juan W; Hong Y; Chun-Yi Z; Hua D
    Int J Hyperthermia; 2018 Dec; 34(8):1289-1297. PubMed ID: 29447020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Short-term outcome of leuprorelin acetate in preventing recurrence of ovarian endometrioma after conservative surgery].
    Yuan L; Wu QJ; Liu XS
    Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):508-10. PubMed ID: 24284221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Mifepristone vs Placebo for Treatment of Adenomyosis With Pain Symptoms: A Randomized Clinical Trial.
    Che X; Wang J; Sun W; He J; Wang Q; Zhu D; Zhu W; Zhang J; Dong J; Xu J; Zheng F; Zhou J; Zhao W; Lin Q; Ye L; Zhao X; Xu Z; Chen Y; Wang J; Wu W; Zhai L; Zhou Y; Zheng J; Zhang X
    JAMA Netw Open; 2023 Jun; 6(6):e2317860. PubMed ID: 37307001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of laparoscopic adenomyomectomy using double-flap method for diffuse uterine adenomyosis.
    Huang X; Huang Q; Chen S; Zhang J; Lin K; Zhang X
    BMC Womens Health; 2015; 15():24. PubMed ID: 25783654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-intensity focused ultrasound (HIFU) combined with gonadotropin-releasing hormone analogs (GnRHa) and levonorgestrel-releasing intrauterine system (LNG-IUS) for adenomyosis: a case series with long-term follow up.
    Haiyan S; Lin W; Shuhua H; Wang W
    Int J Hyperthermia; 2019; 36(1):1179-1185. PubMed ID: 31793356
    [No Abstract]   [Full Text] [Related]  

  • 33. [A study of the controlled ovarian hyperstimulation using GnRH agonist and pure FSH in in vitro fertilization-embryo transfer and gamete intrafallopian transfer program].
    Usui A
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1431-8. PubMed ID: 2511261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP; Macklon NS; Fauser BC
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of laparoscopic ovarian endometriosis cystectomy combined with postoperative GnRH-a therapy on ovarian reserve, pregnancy, and outcome recurrence.
    Yang XH; Ji F; AiLi A; TuerXun H; He Y; Ding Y
    Clin Exp Obstet Gynecol; 2014; 41(3):272-5. PubMed ID: 24992774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrence of uterine adenomyosis after administration of gonadotropin-releasing hormone agonist and the efficacy of dienogest.
    Matsushima T; Akira S; Yoneyama K; Takeshita T
    Gynecol Endocrinol; 2020 Jun; 36(6):521-524. PubMed ID: 31661345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GnRH-a-Induced Perimenopausal Rat Modeling and Black Cohosh Preparations' Effect on Rat's Reproductive Endocrine.
    Chen J; Wang H; Dong Z; Liu J; Qin Z; Bao M; Yu H; Zhang S; Zhang W; Qi C; Wu J
    Front Endocrinol (Lausanne); 2021; 12():683552. PubMed ID: 35002948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of domestic leuprorelin in girls with idiopathic central precocious puberty: a multicenter, randomized, parallel, controlled trial.
    Li WJ; Gong CX; Guo MJ; Xing J; Li T; Song WH; Luo XP; Wu D; Liang JP; Cao BY; Gu Y; Su C; Liang XJ; Liu M; Wang R; Li FT
    Chin Med J (Engl); 2015 May; 128(10):1314-20. PubMed ID: 25963350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of adenomyosis on IVF after long or ultra-long GnRH agonist treatment.
    Hou X; Xing J; Shan H; Mei J; Sun Y; Yan G; Sun H; Wang J
    Reprod Biomed Online; 2020 Nov; 41(5):845-853. PubMed ID: 32972873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.